Inhibition of the IP3R3 subtype reduced breast cancer cell proliferation10, migration, invasion, and survival of glioblastoma cells11 and revealed an oscillating Ca2+ signature along with a slowing down cell migration in human breast cancer cells12. This evidence concerns the gene ITPR3 and breast carcinoma.